An urgent need to scale-up injecting drug harm reduction services in Tanzania: Prevalence of blood-borne viruses among drug users in Temeke District, Dar-es-Salaam, 2011

International Journal of Drug Policy

Volumn 24, Issue 1, 2013, Pages 78-81

  Bowring, Anna L ^a   Luhmann, Niklas ^b   Pont, Sandrine ^c   Debaulieu, Céline ^c   Derozier, Stéphanie ^b   Asouab, Fatima ^b   Toufik, Abdalla ^b   van Gemert, Caroline ^a   Dietze, Paul ^a,d   Stoove, Mark ^a,d  

^a BURNET INSTITUTE   (Australia)

^b République Démocratique du Congo   (France)

^c Médecins du Monde Tanzania ^*  (Tanzania)

^d MONASH UNIVERSITY   (Australia)

Author keywords

Blood borne virus; Harm reduction; HCV; HIV; Injecting drug use; Tanzania

Indexed keywords

ADULT; ARTICLE; BLOODSTREAM INFECTION; FEMALE; HARM REDUCTION; HEALTH SERVICE; HEPATITIS C; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOASSAY; INTRAVENOUS DRUG ABUSE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SCALE UP; TANZANIA; VIRUS TRANSMISSION;

ADULT; COINFECTION; DRUG USERS; FEMALE; HARM REDUCTION; HEALTH BEHAVIOR; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HEALTH SERVICES NEEDS AND DEMAND; HEALTH SURVEYS; HEPATITIS C; HIV INFECTIONS; HUMANS; MALE; PREVALENCE; PRIMARY PREVENTION; QUESTIONNAIRES; RISK FACTORS; SUBSTANCE ABUSE, INTRAVENOUS; TANZANIA; TIME FACTORS; YOUNG ADULT;

EID: 84872500477     PISSN: 09553959     EISSN: 18734758     Source Type: Journal    
DOI: 10.1016/j.drugpo.2012.08.005     Document Type: Article

References (19)

1. Amin J., Law M., Micallef J., Jauncey M., van Beek I., Kaldor J., et al. Potential biases in estimates of hepatitis C RNA clearance in newly acquired hepatitis C infection among a cohort of injecting drug users. Epidemiology and Infection 2007, 135(1):144-150.
2. Chakrapani V., Newman P., Shunmugam M., Dubrow R. Social-structural contexts of needle and syringe sharing behaviours of HIV-positive injecting drug users in Manipur, India: A mixed methods investigation. Harm Reduction Journal 2011, 8(1):9.
3. Dahoma M.J.U., Salim A., Abdool R., Othman A., Makame H., Ali A.S., et al. HIV and substance abuse: The dual epidemics challenging Zanzibar. African Journal of Drug and Alcohol Studies 2006, 5(2):129-138.
4. Debaulieu, C., & Luhmann, N. (2011). Starting comprehensive harm reduction in Temeke District, Dar-es-Salaam, Tanzania. Paper presented at the International Harm Reduction Association Conference, Beirut, Lebanon.
5. McCurdy S.A., Kilonzo G.P., Williams M., Kaaya S. Harm reduction in Tanzania: An urgent need for multisectoral intervention. International Journal of Drug Policy 2007, 18(3):155-159.
6. McCurdy S.A., Ross M.W., Kilonzo G.P., Leshabari M.T., Williams M.L. HIV/AIDS and injection drug use in the neighborhoods of Dar es Salaam, Tanzania. Drug and Alcohol Dependence 2006, 82(Suppl. 1):S23-S27.
7. McCurdy S.A., Ross M.W., Williams M.L., Kilonzo G.P., Leshabari M.T. Flashblood: Blood sharing among female injecting drug users in Tanzania. Addiction 2010, 105(6):1062-1070.
8. McCurdy S.A., Williams M.L., Kilonzo G.P., Ross M.W., Leshabari M.T. Heroin and HIV risk in Dar es Salaam, Tanzania: Youth hangouts, mageto and injecting practices. AIDS Care 2005, 17(Suppl. 1):S65-S76.
9. Nelson P.K., Mathers B.M., Cowie B., Hagan H., Des Jarlais D., Horyniak D., et al. Global epidemiology of hepatitis B and hepatitis C in people who inject drugs: Results of systematic reviews. The Lancet 2011, 378(9791):571-583.
10. Nieburg P., Carty L. HIV prevention among injection drug users in Kenya and Tanzania 2011, Centre for Strategic and International Studies, Washington, DC.
11. Rotman Y., Liang T.J. Coinfection with hepatitis C virus and human immunodeficiency virus: Virological, immunological, and clinical outcomes. Journal of Virology 2009, 83(15):7366-7374.
12. Sharma M., Burrows D., Bluthenthal R.N. Improving coverage and scale-up of HIV prevention, treatment and care for injecting drug users: Moving the agenda forward. International Journal of Drug Policy 2008, 19:1-4.
13. TACAIDS Tanzania HIV/AIDS and Malaria Indicator Survey 2007-08 2009, Tanzania Commission for AIDS (TACAIDS), Zanzibar AIDS Commission, National Bureau of Statistics, Office of the Chief Government Statistician, and Macro International Inc., Dar es Salaam.
14. The Lancet HIV treatment as prevention - It works. The Lancet 2011, 377(9779):1719.
15. UNAIDS Global report: UNAIDS report on the global AIDS epidemic 2010 2010, Joint United Nations Programme on HIV/AIDS (UNAIDS), Geneva.
16. United Nations Office on Drugs and Crime (UNODC). (1999). The drug nexus in Africa. UN Office for Drug Control & Crime Prevention Monographs. Retrieved from . http://www.unodc.org/pdf/report_1999-03-01_1.pdf.
17. WHO, UNODC, UNAIDS WHO, UNODC, UNAIDS technical guide for countries to set targets for universal access to HIV prevention, treatment and care for injecting drug users 2009, World Health Organisation, Geneva.
18. Williams M.L., McCurdy S.A., Bowen A.M., Kilonzo G.P., Atkinson J.S., Ross M.W., et al. HIV seroprevalence in a sample of Tanzanian intravenous drug users. AIDS Education and Prevention 2009, 21(5):474-483.
19. Wilson D.P., Hoare A., Regan D.G., Law M.G. Importance of promoting HIV testing for preventing secondary transmissions: Modelling the Australian HIV epidemic among men who have sex with men. Sex Health 2009, 6(1):19-33.